Concepedia
Statistics
Publications
100
Citations
7.7K
H-Index
47
Active since
1983
Affiliations
The Netherlands Cancer Institute(Current)
Slotervaartziekenhuis
Utrecht University
University of Amsterdam
W.W. ten Bokkel Huinink is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and pharmacology.
Top concepts
MedicinePharmacologyOncologyPharmacotherapyCancer TherapyRadiation OncologyPharmacokineticsOvarian CancerGynecologyCancer Research
Publications per year
1983–2009
European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion.
Elizabeth A. Eisenhauer, W.W. ten Bokkel Huinink, Kenneth D. Swenerton et al. · Journal of Clinical Oncology · 1994 · 640 citations
Increased Oral Bioavailability of Topotecan in Combination With the Breast Cancer Resistance Protein and P-Glycoprotein Inhibitor GF120918
C.M.F. Kruijtzer, Jos H. Beijnen, Hilde Rosing et al. · Journal of Clinical Oncology · 2002 · 456 citations
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.
G.J. Creemers, Giorgio Bolis, M. Gore et al. · Journal of Clinical Oncology · 1996 · 386 citations
Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer
Alexandra W. van den Belt‐Dusebout, Janine Nuver, Ronald de Wit et al. · Journal of Clinical Oncology · 2006 · 349 citations · Full text
Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.
Manon Huizing, Anther Keung, Hilde Rosing et al. · Journal of Clinical Oncology · 1993 · 311 citations
1–5 of 100